RE:A deal is a deal is a deal?Big Name.
Big Money.
No dilution.
The deal is going to be with a Pharma who has their own cell line IMO. It's the only thing that makes sense. People have been talking about Med Tech companies which I think won't happen as the device on it's own at this point in time is kind of useless. The ideal deal would be with a large pharma company who has an advanced cell line. If they have their own anti-rejection tech, that'd be a bonus. They'd need to get into the clinic using their cell line and pay for the clinical trial and pay for use of the device. Not just a little either.
Another scenario could be one of the pharamas that have collaborated with SVA many moons ago. No updates on any of that so potentially could be them wanting to sign something to secure their use/rights to the Cell Ponch for whatever it is they are collaborating on.